Home
>
National Drug Code (NDC)
>
Piperacillin and Tazobactam
Piperacillin and Tazobactam - 0409-3390-51 - (Piperacillin and Tazobactam)
Drug Information of Piperacillin and Tazobactam
| Product NDC: | 0409-3390 |
| Proprietary Name: | Piperacillin and Tazobactam |
| Non Proprietary Name: | Piperacillin and Tazobactam |
| Active Ingredient(s): | 4; .5 g/20mL; g/20mL & nbsp; Piperacillin and Tazobactam |
| Administration Route(s): | INTRAVENOUS; PARENTERAL |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Piperacillin and Tazobactam
| Product NDC: | 0409-3390 |
| Labeler Name: | Hospira, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065362 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101021 |
Package Information of Piperacillin and Tazobactam
| Package NDC: | 0409-3390-51 |
| Package Description: | 10 VIAL, SINGLE-USE in 1 CARTON (0409-3390-51) > 20 mL in 1 VIAL, SINGLE-USE |
NDC Information of Piperacillin and Tazobactam
| NDC Code | 0409-3390-51 |
| Proprietary Name | Piperacillin and Tazobactam |
| Package Description | 10 VIAL, SINGLE-USE in 1 CARTON (0409-3390-51) > 20 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 0409-3390 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Piperacillin and Tazobactam |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS; PARENTERAL |
| Start Marketing Date | 20101021 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira, Inc |
| Substance Name | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
| Strength Number | 4; .5 |
| Strength Unit | g/20mL; g/20mL |
| Pharmaceutical Classes | beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |
